Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Hancheng Liu

dblp:330/9817 · DBLP profile ↗
← Back
4ranked-venue papers
0as first author
4since 2021 · last 2025
—ORCID · conflict

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 4 · 4 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
4 papers
Bioinformatics and computational biology · 95% Medical and health informatics · 5%

Topics — the 4 heaviest of 4, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology
protein function prediction
2.532025
GOAnnotator: accurate protein function annotation using automatically retrieved literature · Bioinform. 2025
DualGOFiller: A Dual-Channel Graph Neural Network with Contrastive Learning for Enhancing Function Prediction in Partially Annotated Proteins · RECOMB 2025
GORetriever: reranking protein-description-based GO candidates by literature-driven deep information retrieval for protein function annotation · Bioinform. 2024
Bioinformatics and computational biology › drug discovery › drug response prediction
cancer drug response prediction
0.612022
Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions · Bioinform. 2022
Bioinformatics and computational biology › biomedical text mining
biomedical literature retrieval
0.522025
GOAnnotator: accurate protein function annotation using automatically retrieved literature · Bioinform. 2025
GORetriever: reranking protein-description-based GO candidates by literature-driven deep information retrieval for protein function annotation · Bioinform. 2024
Medical and health informatics › precision medicine
personalized treatment
0.212022
Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions · Bioinform. 2022

Methods — techniques the papers use, named apart from their topics

re-ranking · 1.6deep information retrieval · 1.6graph neural network · 1.4hybrid retrieval · 0.9contrastive learning · 0.9semantic matching · 0.8neighborhood interaction · 0.6heterogeneous graph convolutional network · 0.6
YearPublicationVenuePosition
2025 DualGOFiller: A Dual-Channel Graph Neural Network with Contrastive Learning for Enhancing Function Prediction in Partially Annotated Proteins
Hancheng Liu, Weiqi Zhai, Shanfeng Zhu
RECOMB2
2025 GOAnnotator: accurate protein function annotation using automatically retrieved literature
abstract
SUMMARY: Automated protein function prediction/annotation (AFP) is vital for understanding biological processes and advancing biomedical research. Existing text-based AFP methods including the state-of-the-art method, GORetriever, rely on expert-curated relevant literature, which is costly and time-consuming, and cover only a small portion of the proteins in UniProt. To overcome this limitation, we propose GOAnnotator, a novel framework for automated protein function annotation. It consists of two key modules: PubRetriever, a hybrid system for retrieving and re-ranking relevant literature, and GORetriever+, an enhanced module for identifying Gene Ontology (GO) terms from the retrieved texts. Extensive experiments over three benchmark datasets demonstrate that GOAnnotator delivers high-quality functional annotations, surpassing GORetriever in realistic situations by uncovering unique literature and predicting additional functions. These results highlight its great potential to streamline and enhance annotation of protein functions without relying on manual curation. AVAILABILITY AND IMPLEMENTATION: The code and data are available at https://github.com/ZhuLab-Fudan/GOAnnotator.
Huiying Yan, Hancheng Liu, Shanfeng Zhu
Bioinform.2
2024 GORetriever: reranking protein-description-based GO candidates by literature-driven deep information retrieval for protein function annotation
abstract
SUMMARY: The vast majority of proteins still lack experimentally validated functional annotations, which highlights the importance of developing high-performance automated protein function prediction/annotation (AFP) methods. While existing approaches focus on protein sequences, networks, and structural data, textual information related to proteins has been overlooked. However, roughly 82% of SwissProt proteins already possess literature information that experts have annotated. To efficiently and effectively use literature information, we present GORetriever, a two-stage deep information retrieval-based method for AFP. Given a target protein, in the first stage, candidate Gene Ontology (GO) terms are retrieved by using annotated proteins with similar descriptions. In the second stage, the GO terms are reranked based on semantic matching between the GO definitions and textual information (literature and protein description) of the target protein. Extensive experiments over benchmark datasets demonstrate the remarkable effectiveness of GORetriever in enhancing the AFP performance. Note that GORetriever is the key component of GOCurator, which has achieved first place in the latest critical assessment of protein function annotation (CAFA5: over 1600 teams participated), held in 2023-2024. AVAILABILITY AND IMPLEMENTATION: GORetriever is publicly available at https://github.com/ZhuLab-Fudan/GORetriever.
Huiying Yan, Hancheng Liu, Hiroshi Mamitsuka, Shanfeng Zhu
Bioinform.3
2022 Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions
abstract
MOTIVATION: Due to cancer heterogeneity, the therapeutic effect may not be the same when a cohort of patients of the same cancer type receive the same treatment. The anticancer drug response prediction may help develop personalized therapy regimens to increase survival and reduce patients' expenses. Recently, graph neural network-based methods have aroused widespread interest and achieved impressive results on the drug response prediction task. However, most of them apply graph convolution to process cell line-drug bipartite graphs while ignoring the intrinsic differences between cell lines and drug nodes. Moreover, most of these methods aggregate node-wise neighbor features but fail to consider the element-wise interaction between cell lines and drugs. RESULTS: This work proposes a neighborhood interaction (NI)-based heterogeneous graph convolution network method, namely NIHGCN, for anticancer drug response prediction in an end-to-end way. Firstly, it constructs a heterogeneous network consisting of drugs, cell lines and the known drug response information. Cell line gene expression and drug molecular fingerprints are linearly transformed and input as node attributes into an interaction model. The interaction module consists of a parallel graph convolution network layer and a NI layer, which aggregates node-level features from their neighbors through graph convolution operation and considers the element-level of interactions with their neighbors in the NI layer. Finally, the drug response predictions are made by calculating the linear correlation coefficients of feature representations of cell lines and drugs. We have conducted extensive experiments to assess the effectiveness of our model on Cancer Drug Sensitivity Data (GDSC) and Cancer Cell Line Encyclopedia (CCLE) datasets. It has achieved the best performance compared with the state-of-the-art algorithms, especially in predicting drug responses for new cell lines, new drugs and targeted drugs. Furthermore, our model that was well trained on the GDSC dataset can be successfully applied to predict samples of PDX and TCGA, which verified the transferability of our model from cell line in vitro to the datasets in vivo. AVAILABILITY AND IMPLEMENTATION: The source code can be obtained from https://github.com/weiba/NIHGCN. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Wei Peng 0004, Hancheng Liu, Wei Dai 0012, Ning Yu 0004, Jianxin Wang 0001
Bioinform.2